On July 15, 2020, Neptune Wellness Solutions Inc. (the “Company”), a health and wellness company focused on extraction, purification and formulation of cannabinoids, closed its previously announced registered direct offering with certain healthcare-focused institutional investors for the sale of 4,773,584 common shares at an offering price of US$2.65 per share for gross proceeds of approximately US$12.65 million before deducting fees and other estimated offering expenses, pursuant to a registered direct offering.
The offering was made in the United States only under the Company's short form base shelf prospectus dated February 22, 2019, filed with the securities regulatory authorities in each of the provinces and territories of Canada, and the corresponding registration statement on Form F-10 filed by the Company with the U.S. Securities and Exchange Commission under the U.S./Canada Multijurisdictional Disclosure System.
Fasken advised the issuer in this transaction with a team composed of Krisztián Tóth from the Toronto office, and Peter Villani and Oleg Stratiev from the Montreal office.
